Results 11 to 20 of about 2,655,766 (243)
Self-administration of augmentation therapy for alpha 1-antitrypsin deficiency [PDF]
IJTLD OpenSelf-administration of augmentation therapy for alpha 1-antitrypsin ...
A. Vianello +14 more
doaj +4 more sources
Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies
Therapeutic Advances in Respiratory Disease, 2010 Alpha-1 antitrypsin (AAT) deficiency is a hereditary condition characterized by low levels of AAT in plasma and hence diffusion into tissues. One of the most relevant characteristics of the disease is the development of panacinar emphysema due to an ...
Adriano R. Tonelli, Mark L. Brantly
doaj +3 more sources
Biologics: Targets & Therapy, 2009 Irina Petrache1, Joud Hajjar1, Michael Campos21Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA; 2Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Miller School of Medicine ...
Irina Petrache +2 more
doaj +1 more source
D-cycloserine augmentation in behavioral therapy for obsessive-compulsive disorder: a meta-analysis
Drug Design, Development and Therapy, 2015 Jing Xia,1 Yanqiu Du,2 Jiyang Han,1 Guo Liu,1 Xumei Wang11Department of Psychiatry, Shengjing Hospital of China Medical University, Heping District Shenyang, Liaoning, People’s Republic of China; 2Department of Medicine, Shenyang Ninth People’
Xia J, Du Y, Han J, Liu G, Wang X
doaj +1 more source
Gene augmentation therapy attenuates retinal degeneration in a knockout mouse model of Fam161a retinitis pigmentosa. [PDF]
Mol Ther, 2023 Photoreceptor cell degeneration and death is the major hallmark of a wide group of human blinding diseases including age-related macular degeneration and inherited retinal diseases such as retinitis pigmentosa. In recent years, inherited retinal diseases
Matsevich C +9 more
europepmc +2 more sources
Alpha-1 Antitrypsin Deficiency: Home Therapy
Frontiers in Pharmacology, 2021 While available in only a few countries, home therapy is a possible strategy for the treatment of alpha-1 antitrypsin deficiency. We want to describe our experience in the management of human alpha-1 antitrypsin using home care intravenous augmentation ...
Anna Annunziata +5 more
doaj +1 more source
Alveolar ridge preservation reduces the need for ancillary bone augmentation in the context of implant therapy [PDF]
, 2022 BACKGROUND: There is limited information on the need for bone augmentation in the context of delayed implant placement whether alveolar ridge preservation (ARP) is previously performed or not.
Emilio Couso‐Queiruga +17 more
core +2 more sources
COPD, 2021 Pulmonary events (PEs) associated with alpha-1 antitrypsin deficiency (AATD) can have a severe clinical course and increase healthcare resource use (HRU). However, AATD-associated HRU and healthcare costs have not been extensively described.
Ernesto Mayen Herrera +4 more
doaj +1 more source
Case report: Self-administration of alpha-1 antitrypsin therapy: a report of two cases
Frontiers in Pharmacology, 2023 Intravenous augmentation therapy with human alpha-1 proteinase inhibitor for the management of respiratory disease is recommended for people with alpha-1 antitrypsin deficiency (AATD) who are nonsmokers or former smokers.
Ana M. Escribano Dueñas +3 more
doaj +1 more source
“Metacognitive Reflection and Insight Therapy” (MERIT) for the Occupational Therapy Practitioner [PDF]
, 2022 Background: Metacognitive Reflection and Insight Therapy (MERIT) is a manualized, evidence-based approach that supports occupational participation through its focus on the inter-related constructs of meaning making, positionality, and self-definition ...
Lysaker, Paul H. +3 more
core +1 more source